$INJ ETF UPDATE 🔥
Injective is getting closer to traditional markets.
21Shares has filed an updated S-1 for its proposed Injective ETF, giving $INJ a clearer look at how the fund could work.
and there are some interesting details inside ⚶
✦ 40–60% of the funda INJ holdings could be staked, with flexibility depending on liquidity needs.
✦ the ETF is proposed to list on Nasdaq under TINJ.
✦ The FTSE Injective Index would be used as the pricing benchmark.
✦ BNY Mellon is named as the administrator, transfer agent and cash custodian.
and honestly, the staking part is pretty interesting.
the fund could stake a significant portion of its holdings while still keeping enough flexibility to handle liquidity needs.
why is this important?
coz it creates a more familiar route for traditional investors to gain exposure to Injective.
if approved, investors could access $INJ through an ETF without having to worry about buying, holding or managing the token themselves.
the structure is getting clearer.
one more step toward bringing @Injective to a much wider market 🥷
Injective is getting closer to traditional markets.
21Shares has filed an updated S-1 for its proposed Injective ETF, giving $INJ a clearer look at how the fund could work.
and there are some interesting details inside ⚶
✦ 40–60% of the funda INJ holdings could be staked, with flexibility depending on liquidity needs.
✦ the ETF is proposed to list on Nasdaq under TINJ.
✦ The FTSE Injective Index would be used as the pricing benchmark.
✦ BNY Mellon is named as the administrator, transfer agent and cash custodian.
and honestly, the staking part is pretty interesting.
the fund could stake a significant portion of its holdings while still keeping enough flexibility to handle liquidity needs.
why is this important?
coz it creates a more familiar route for traditional investors to gain exposure to Injective.
if approved, investors could access $INJ through an ETF without having to worry about buying, holding or managing the token themselves.
the structure is getting clearer.
one more step toward bringing @Injective to a much wider market 🥷
